BULL CERTIFICATE - ORION B Stock

Certificat

BULL ORION X2 N

SE0016279418

Market Closed - Bid/Ask 07:16:04 2024-05-28 EDT			After market 11:25:00
9 ^EUR	+2.27%		9.66	+7.33%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart ORION OYJ

Latest news about ORION OYJ

Orion Partners with Universities for Biotechnology Project in Finland	06-03	MT
Orion is developing the Finnish life science industry in a unique collaboration project	06-03	GL
Orion Corporation: Change in Orion Group Executive Management Board as of 31 May 2025	05-07	GL
Orion Corporation Announces Change in Orion Group Executive Management Board as of 31 May 2025	05-07	CI

More news

Static data

Product type	Exotic Products
Buy / Sell	CALL
Underlying	ORION OYJ
Issuer	Nordea
	BULL ORION X2 N
ISIN	SE0016279418
Date issued	2021-07-08
Maturity	Unlimited
Parity	1 : 1
Emission price	- €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	17.78 €
Lowest since issue	6.63 €
Spread	0.06 €
Spread %	0.62%

Company Profile

Orion Oyj is Finland's leading pharmaceutical group. Net sales break down by family products and services as follows: - generic, OTC and biosimilar drugs (43.4%); - patented prescription products (41.7%): notably intended for treating dysfunctions of the nervous system, cardiovascular diseases, hormonal and urological treatments; - animal health products (8.7%); - pharmaceutical ingredients and outsourcing services (6.2%). Net sales break down primarily by source of revenue between sales of products (86.9%) and royalties (10.4%). Net sales are distributed geographically as follows: Finland (28%), Scandinavia (12%), Europe (30.8%), North America (14.7%) and other (14.5%).

Sector

More about the company